The Quality Control Team at Akero Therapeutics ensures the integrity and consistency of clinical trial materials and processes. They oversee the validation and regulation of critical reagents, maintaining high standards of quality for Akero's lead product candidate, efruxifermin (EFX). This team plays a crucial role in the success of Akero’s clinical-stage research by guaranteeing compliance with industry standards and regulatory requirements.